{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:09:47Z","timestamp":1788397787929,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ak0101080"],"award-info":[{"award-number":["18ak0101080"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JP171024167"],"award-info":[{"award-number":["JP171024167"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xphs.2024.10.051","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:26:35Z","timestamp":1730463995000},"page":"103596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progressive amyloid-\u03b2 accumulation in the brain leads to altered protein expressions in the liver and kidneys of APP knock-in mice"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8862-471X","authenticated-orcid":false,"given":"Shingo","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsumi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-7823","authenticated-orcid":false,"given":"Seiryo","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-4783","authenticated-orcid":false,"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-9251","authenticated-orcid":false,"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-7133","authenticated-orcid":false,"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2024.10.051_bib0001","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.051_bib0002","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.051_bib0003","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresrev.2007.09.001","article-title":"Common pathological processes in Alzheimer disease and type 2 diabetes: a review","volume":"56","author":"Li","year":"2007","journal-title":"Brain Res Rev"},{"issue":"Pt A","key":"10.1016\/j.xphs.2024.10.051_bib0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exger.2016.11.012","article-title":"Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II","volume":"87","author":"Nakagawa","year":"2017","journal-title":"Exp Gerontol"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.051_bib0005","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J"},{"issue":"15","key":"10.1016\/j.xphs.2024.10.051_bib0006","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xphs.2024.10.051_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","article-title":"Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model","volume":"13","author":"Kim","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.051_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2003-5101","article-title":"Apolipoprotein E influences amyloid-beta clearance from the murine periphery","volume":"5","author":"Hone","year":"2003","journal-title":"J Alzheimers Dis"},{"issue":"44","key":"10.1016\/j.xphs.2024.10.051_bib0009","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer's Abeta40 and Abeta42","volume":"279","author":"Ghiso","year":"2004","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.051_bib0010","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","article-title":"Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver","volume":"23","author":"Tamaki","year":"2006","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.051_bib0011","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","article-title":"Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer's disease","volume":"26","author":"Tian","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"5284","key":"10.1016\/j.xphs.2024.10.051_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science (New York, NY)"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.051_bib0013","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.051_bib0014","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.0022-3042.2001.00724.x","article-title":"Elevated hepatic and depressed renal cytochrome P450 activity in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"80","author":"Van Ess","year":"2002","journal-title":"J Neurochem"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.051_bib0015","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1021\/acs.molpharmaceut.8b00500","article-title":"Altered expression of small intestinal drug transporters and hepatic metabolic enzymes in a mouse model of familial Alzheimer's disease","volume":"15","author":"Pan","year":"2018","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.051_bib0016","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.xphs.2019.02.016","article-title":"Increased expression of renal drug transporters in a mouse model of familial Alzheimer's disease","volume":"108","author":"Pan","year":"2019","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.051_bib0017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.051_bib0018","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12987-023-00466-9","article-title":"Proteomic alterations in the brain and blood-brain barrier during brain Abeta accumulation in an APP knock-in mouse model of Alzheimer's disease","volume":"20","author":"Ito","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.051_bib0019","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/acs.molpharmaceut.6b00259","article-title":"Effect of intestinal flora on protein expression of drug-metabolizing enzymes and transporters in the liver and kidney of germ-free and antibiotics-treated mice","volume":"13","author":"Kuno","year":"2016","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.051_bib0020","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1021\/acs.molpharmaceut.0c00547","article-title":"Proteomic evaluation of plasma membrane fraction prepared from a mouse liver and kidney using a bead homogenizer: enrichment of drug-related transporter proteins","volume":"17","author":"Yagi","year":"2020","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.051_bib0021","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ","volume":"13","author":"Cox","year":"2014","journal-title":"Mol Cell Proteom"},{"issue":"D1","key":"10.1016\/j.xphs.2024.10.051_bib0022","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.051_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"7691","key":"10.1016\/j.xphs.2024.10.051_bib0024","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.051_bib0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/tpj.2017.5","article-title":"Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues","volume":"18","author":"Tourancheau","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.051_bib0026","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol Rev"},{"issue":"15\u201316","key":"10.1016\/j.xphs.2024.10.051_bib0027","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/pmic.201500433","article-title":"Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: comparison with MRM\/SRM and HR-MRM\/PRM","volume":"16","author":"Nakamura","year":"2016","journal-title":"Proteomics"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.051_bib0028","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2217\/14622416.7.8.1211","article-title":"Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping","volume":"7","author":"Innocenti","year":"2006","journal-title":"Pharmacogenomics"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.051_bib0029","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/FPC.0b013e32832e0eac","article-title":"Codeine and morphine pathway","volume":"19","author":"Thorn","year":"2009","journal-title":"Pharmacogenet. Genom"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.051_bib0030","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/dmd.107.019281","article-title":"Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties","volume":"36","author":"Ohno","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.051_bib0031","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/dmd.31.9.1086","article-title":"Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7","volume":"31","author":"Stone","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.051_bib0032","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/dmd.111.043356","article-title":"Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform","volume":"40","author":"Ma","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.051_bib0033","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00228-007-0261-0","article-title":"Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver","volume":"63","author":"Mano","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.051_bib0034","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1021\/acs.molpharmaceut.7b00179","article-title":"Contribution of MATE1 to renal secretion of the NMDA receptor antagonist memantine","volume":"14","author":"Muller","year":"2017","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.051_bib0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11095-019-2674-8","article-title":"Changes of Blood-brain barrier and brain parenchymal protein expression levels of mice under different insulin-resistance conditions induced by high-fat diet","volume":"36","author":"Ogata","year":"2019","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.051_bib0036","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.051_bib0037","first-page":"226","article-title":"Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics","volume":"14","author":"Huang","year":"2013","journal-title":"Curr Drug Metab"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.051_bib0038","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"7806","key":"10.1016\/j.xphs.2024.10.051_bib0039","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.051_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.051_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.051_bib0042","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.18632\/oncotarget.23305","article-title":"Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status","volume":"9","author":"Belkahla","year":"2018","journal-title":"Oncotarget"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924005033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924005033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:32:57Z","timestamp":1754479977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924005033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0022354924005033"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.051","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive amyloid-\u03b2 accumulation in the brain leads to altered protein expressions in the liver and kidneys of APP knock-in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"103596"}}